| Lung Cancer Treatments and Mutations | Lifetime | 19 | US 14 | 99.93 |
| Cancer Genomics and Diagnostics | Lifetime | 100 | US 66 | 99.74 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 88 | US 51 | 99.76 |
| Lung Cancer Research Studies | Lifetime | 63 | US 34 | 99.67 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 96 | US 49 | 99.66 |
| Colorectal Cancer Treatments and Studies | Lifetime | 120 | US 56 | 99.55 |
| Angiogenesis and VEGF in Cancer | Lifetime | 112 | US 54 | 99.16 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 375 | US 183 | 98.90 |
| RNA modifications and cancer | Lifetime | 913 | US 438 | 98.33 |
| Neuroendocrine Tumor Research Advances | Lifetime | 421 | US 174 | 98.49 |
| HER2/EGFR in Cancer Research | Lifetime | 354 | US 168 | 98.47 |
| Ferroptosis and cancer prognosis | Lifetime | 313 | US 90 | 96.43 |
| Cancer therapeutics and mechanisms | Lifetime | 390 | US 218 | 97.91 |
| Vascular Tumors and Angiosarcomas | Lifetime | 227 | US 117 | 96.94 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 631 | US 345 | 95.49 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 6 | US 2 | 99.96 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 7 | US 1 | 99.85 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 33 | US 9 | 99.86 |
| Lung Cancer Research Studies | 2021-2025 | 32 | US 13 | 99.46 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 34 | US 13 | 99.39 |
| Cancer Genomics and Diagnostics | 2021-2025 | 138 | US 71 | 98.93 |
| HER2/EGFR in Cancer Research | 2021-2025 | 63 | US 25 | 98.95 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 420 | US 91 | 96.63 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 283 | US 96 | 95.18 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 264 | US 70 | 94.36 |
| Radiomics and Machine Learning in Medical Imaging | 2021-2025 | 992 | US 204 | 94.54 |
| CAR-T cell therapy research | 2021-2025 | 863 | US 465 | 95.14 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 524 | US 232 | 94.89 |
| Peptidase Inhibition and Analysis | 2021-2025 | 430 | US 114 | 92.21 |
| Genetic factors in colorectal cancer | 2021-2025 | 786 | US 261 | 88.04 |
| Cancer therapeutics and mechanisms | 2021-2025 | 515 | US 117 | 80.78 |
| Cancer Research and Treatments | 2021-2025 | 794 | US 209 | 80.30 |
| Cancer Mechanisms and Therapy | 2021-2025 | 573 | US 75 | 78.51 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 461 | US 163 | 71.51 |
| Chromatin Remodeling and Cancer | 2021-2025 | 781 | US 314 | 58.34 |
